Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
NewBiotics
company
About
NewBiotics' strategy is to transform drug resistance into therapeutic advantage.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $11M
- Industries
- Health Care,Medical,Therapeutics
- Founded date
- Sep 1, 1997
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NewBiotics transforms drug resistances into therapeutic advantages. It focuses on the discovery and development of drug molecules that leverage the cycle of drug resistance in both cancer and infectious diseases.NewBiotics is a U.S.-based company that was founded in 1997 and the company was acquired by Celmed Biosciences on June 7, 2004.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$21.87M
NewBiotics has raised a total of
$21.87M
in funding over 2 rounds. Their latest funding was raised on
Apr 27, 2004 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 27, 2004 | Series E | $4.57M | 1 | — | — | Detail |
| Jul 25, 2001 | Series C | $11M | 3 | — | — | Detail |
| Apr 4, 2000 | Series Unknown | $6.30M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
NewBiotics is funded by 3 investors.
Inglewood Ventures
and Cheng Xin Technology Development Corp
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series E |
|
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
